Core Viewpoint - Two Hong Kong companies, Yuejiang (02432.HK) and Yaoshibang (09885.HK), have signed a strategic cooperation agreement to explore the application of intelligent robotics and AI in the pharmaceutical industry, aiming to enhance efficiency and innovation across the entire supply chain [1][2]. Group 1: Strategic Cooperation - The partnership will focus on the development and deployment of intelligent robots in pharmacies and drug warehouses, with both companies sharing technology and intellectual property generated during the collaboration [2]. - Yuejiang will handle technology development, production, and maintenance of the robots, while Yaoshibang will focus on application research and sales [1][2]. Group 2: Market Potential - According to a report by ZhiShi Industry Consulting, the global collaborative robot market in the healthcare sector is expected to reach $373 million by 2028, indicating significant growth potential [3]. - Yuejiang anticipates that the pharmaceutical sector will become a key area for the application and promotion of collaborative robots [3]. Group 3: Company Performance - On June 3, Yuejiang's stock rose by 0.87%, with a market capitalization exceeding HKD 20 billion, reflecting a year-to-date increase of 144.30% [3]. - Yaoshibang's stock increased by 4.79% on the same day, with a market capitalization of approximately HKD 6.9 billion and a year-to-date rise of 78.37% [3].